Barclays PLC Pfizer Inc Transaction History
Barclays PLC
- $327 Billion
- Q2 2024
A detailed history of Barclays PLC transactions in Pfizer Inc stock. As of the latest transaction made, Barclays PLC holds 15,242,809 shares of PFE stock, worth $419 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
15,242,809
Previous 21,565,306
29.32%
Holding current value
$419 Million
Previous $598 Million
28.73%
% of portfolio
0.13%
Previous 0.21%
Shares
28 transactions
Others Institutions Holding PFE
# of Institutions
3,253Shares Held
3.72BCall Options Held
73.5MPut Options Held
108M-
Vanguard Group Inc Valley Forge, PA511MShares$14 Billion0.28% of portfolio
-
Black Rock Inc. New York, NY424MShares$11.7 Billion0.27% of portfolio
-
State Street Corp Boston, MA287MShares$7.88 Billion0.36% of portfolio
-
Wellington Management Group LLP Boston, MA166MShares$4.57 Billion0.85% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA117MShares$3.22 Billion0.63% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $154B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...